High prevalence of winter 25-hydroxyvitamin D deficiency despite supplementation according to guidelines for hemodialysis patients

Clinical and Experimental Nephrology

Volumn 16, Issue 6, 2012, Pages 945-951

  González Parra, Emilio ^a,b   Avila, Pablo Justo ^a   Mahillo Fernández, Ignacio ^a   Lentisco, Carolina ^a   Gracia, Carolina ^a   Egido, Jesús ^a,b   Ortiz, Alberto ^a,b  

^a 28400 Madrid   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

25 Hydroxyvitamin D; Calcifediol; Hemodialysis; Seasonal; Supplementation

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARICALCITOL;

25 HYDROXYVITAMIN D DEFICIENCY; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DIURESIS; DOSE RESPONSE; DRUG MEGADOSE; DRY WEIGHT; FEMALE; FOLLOW UP; HEALTH IMPACT ASSESSMENT; HEMODIALYSIS PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEASONAL VARIATION; SUMMER; TREND STUDY; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WINTER;

AGED; AGED, 80 AND OVER; CALCIUM; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SEASONS; SPAIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84876283594     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0642-2     Document Type: Article

References (23)

1. Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, et al. Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr. 2010;140:542-50.
2. Dusso AS, Tokumoto M. Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int. 2011;79:715-29.
3. Rojas J, De La Piedra C, Ramos AM, Ortiz A, Egido J. The expanding spectrum of biological actions of vitamin D. Nephrol Dial Transplant. 2010;25:2850-65.
4. Bolland MJ, Ames RW, Grey AB, Horne AM, Mason BH, Gamble GD, et al. The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr. 2007;86:959-64.
5. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, Calle EE, et al. Comparing methods for accounting for seasonal variability in biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin D. Am J Epidemiol. 2009;170:88-94.
6. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol. 2010;5:905-11.
7. Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C, et al. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. 2011;26:1024-32.
8. Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest. 2005;115:177-86.
9. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25OH vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int. 2007;11:315-21.
10. Clements MR, Johnson L, Fraser DR. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature. 1987;325:62-5.
11. Elder GJ. Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology. 2007;12:90-4.
12. Tolouian R, Rao DS, Goggins M, Bhat S, Gupta A. Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol. 2010;74:19-24.
13. Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009;24:611-8.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-201.
15. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-S130.
16. Torregrosa JV, Bover J, Cannata J, Lorenzo V, de Francisco ALM, Martínez I, et al. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Nefrologia 2011;31 Suppl(1): 1-32.
17. Jones G. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial. 2010;23:239-43.
18. Nigwekar SU, Bhan I, Thadhani R. Nutritional vitamin D in dialysis patients: what to D-iscern? Nephrol Dial Transplant. 2011;26:764-6.
19. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72:1004-13.
20. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, et al. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kid Dis. 2009 Jun;53(6):1024-33.
21. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009;75:88-95.
22. Ramos AM, Albalate M, Vázquez S, Caramelo C, Egido J, Ortiz A. Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients. Kidney Int Suppl. 2008;111:S88-93.
23. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant. 2008;23:3670-6.